Monday, June 22, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 741 of 1,261

  1. US 9095608

    Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

    The Regents of the University of Colorado · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  2. US 9095612

    Halogenated compounds for photodynamic therapy

    NANOQUANTUM SCIENCES, INC. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  3. US 9095621

    Oligome-bis-chromonyl compound conjugates

    Nektar Therapeutics · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  4. US 9095597

    N-acetyl mannosamine as a therapeutic agent

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  5. US 9095579

    Protection and treatment against influenza infection

    The Regents of the University of California · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  6. US 9095562

    Methods and compositions for optimized expansion and implantation of mesenchymal stem cells

    REGENERATIVE SCIENCES, LLC · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  7. US 9095572

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  8. US 9095571

    Pro-neurogenic compounds

    The Board of Regents of the University of Texas System · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  9. US 9095550

    Methods for treating diabetic wounds

    CALREGEN INC. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  10. US 9095539

    Anti-adhesin based passive immunoprophylactic

    United States of America as represented by the Secretary of the Air Force · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  11. US 9095515

    Ezetimibe compositions

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  12. FR 3016881

    TRAITEMENT DES DEGENERESCENCES ET DES LESIONS PHOTO-INDUITES DE LA RETINE

    BIOCODEX [FR] · Granted Jul 31, 2015 · Expires Jul 26, 2035

    granted

  13. US 9089506

    Stable, non-irritating topical formulations of hydroquinone

    Precision Dermatology, Inc. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  14. US 9090873

    Development of dengue virus vaccine components

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  15. US 9090630

    Macrocyclic FLT3 kinase inhibitors

    Oncodesign SA · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  16. US 9090597

    Pyrazolone derivatives as PDE4 inhibitors

    TAKEDA GMBH · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  17. US 9090573

    Compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  18. US 9089545

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  19. US 9090589

    Specific nNOS inhibitors for the therapy and prevention of human melanoma

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  20. US 9091701

    Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  21. US 9089677

    Transcutaneous multimodal delivery system (TMDS)

    The Regents of the University of California · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  22. US 9091696

    Modulation of NR2F6 and methods and uses thereof

    Regen Biopharma, Inc. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  23. US 9090895

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  24. US 9090712

    Diagnosis of carcinomas

    PACIFIC NORTHWEST RESEARCH INSTITUTE · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.